Robert J. Spiegel - Jun 10, 2021 Form 4 Insider Report for Ayala Pharmaceuticals, Inc. (AYLA)

Role
Director
Signature
/s/ Roni Mamluk, Ph.D., Attorney-in-Fact for Robert J. Spiegel, M.D.
Stock symbol
AYLA
Transactions as of
Jun 10, 2021
Transactions value $
$0
Form type
4
Date filed
6/14/2021, 05:03 PM
Previous filing
May 13, 2021
Next filing
Jun 17, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AYLA Stock Option (Right to Buy) Award $0 +6.25K $0.00 6.25K Jun 10, 2021 Common Stock 6.25K $10.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable on the earlier of (i) June 10, 2022 or (ii) one day prior to the Company's 2022 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date.